Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Jie D'Elia
SENIOR VICE PRESIDENT, BUSINESS DEVELOPMENT, ONCOLOGY, HEMATOLOGY & CELL THERAPY, BRISTOL MYERS SQUIBB
In today’s disruptive health care environment, how will biotech transform?
Placeholder Photo
Paul Dabrowski
CEO, SYNTHEGO CORPORATION
Synthego Corporation
Redwood City, California, United States
Placeholder Photo
Steven Damon, PhD
CEO, MICRON BIOMEDICAL, INC.
Micron Biomedical
Atlanta, Georgia, United States
Placeholder Photo
Selena Daniels, PharmD, MS
TEAM LEADERS, CLINICAL OUTCOME ASSESSMENTS STAFF, OND, CDER, FDA
Enhancing Meaningful Engagement on Patient Experience Data in Drug Development
Steve Darnell, PhD
PRINCIPAL SCIENTIST, DNASTAR, INC.
DNASTAR
Madison, Wisconsin, United States
Debanu Das, ACA
CEO, XPOSE THERAPEUTICS INC.
XPose Therapeutics
San Carlos, California, United States
Placeholder Photo
Ebony Dashiell-Aje, PhD
EXECUTIVE DIRECTOR, PATIENT CENTERED OUTCOMES SCIENCE, BIOMARIN
Enhancing Meaningful Engagement on Patient Experience Data in Drug Development
Placeholder Photo
Matt Davidson
CEO, AZORA THERAPEUTICS
Azora Therapeutics
Stephanie Davis
PROGRAM SPECIALIST, NATIONAL INSTITUTES OF HEALTH
NIH Efforts for Supporting Small Business Entrepreneurs from Diverse Backgrounds
Bethesda, Maryland, United States
Michelle Davis
M&A REPORTER, BLOOMBERG NEWS
Fireside Chat with Christopher Viehbacher, President and Chief Executive Officer, Biogen